Scilex Holding (NASDAQ:SCLXW – Get Free Report)’s share price dropped 4.8% on Monday . The stock traded as low as $0.20 and last traded at $0.20. Approximately 5,341 shares traded hands during mid-day trading, an increase of 46% from the average daily volume of 3,667 shares. The stock had previously closed at $0.21.
Scilex Stock Down 4.8 %
The company has a fifty day simple moving average of $0.25 and a two-hundred day simple moving average of $0.29.
About Scilex
Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical system) 1.8% (ZTlido), a prescription lidocaine topical product for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a ready-to-use oral solution for the acute treatment of migraine with or without aura in adults; and GLOPERBA, a liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.
Featured Stories
- Five stocks we like better than Scilex
- What is the MACD Indicator and How to Use it in Your Trading
- How to Invest in Small Cap Stocks
- 3 Warren Buffett Stocks to Buy Now
- These Are the Dividend Stocks Insiders Bought in January
- What Do S&P 500 Stocks Tell Investors About the Market?
- How the ‘No Buy’ Trend of 2025 Is Boosting These 3 Stocks
Receive News & Ratings for Scilex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scilex and related companies with MarketBeat.com's FREE daily email newsletter.
